Artemis Medicare Services Limited

NSEI:ARTEMISMED Stock Report

Market Cap: ₹31.5b

Artemis Medicare Services Past Earnings Performance

Past criteria checks 4/6

Artemis Medicare Services has been growing earnings at an average annual rate of 32.2%, while the Healthcare industry saw earnings growing at 28.4% annually. Revenues have been growing at an average rate of 13.5% per year. Artemis Medicare Services's return on equity is 10.8%, and it has net margins of 5.6%.

Key information

32.2%

Earnings growth rate

31.8%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate13.5%
Return on equity10.8%
Net Margin5.6%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

Jul 16
Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Apr 13
After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Jun 14
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Mar 15
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Aug 31
Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Jul 30
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

May 13
Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Jan 11
Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Dec 10
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Sep 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Jul 01
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

May 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Mar 16
We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Jan 22
Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Nov 13
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Jul 20
Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Revenue & Expenses Breakdown

How Artemis Medicare Services makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:ARTEMISMED Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 248,786491850
31 Dec 238,4864561060
30 Sep 238,1734451060
30 Jun 237,7974001060
31 Mar 237,3743861060
31 Dec 226,916412600
30 Sep 226,482373600
30 Jun 225,997363600
31 Mar 225,548318600
31 Dec 215,345313360
30 Sep 215,147301360
30 Jun 214,680221360
31 Mar 214,08465360
31 Dec 204,177-19540
30 Sep 204,370-16540
30 Jun 204,9203800
31 Mar 205,650198540
31 Dec 195,667211720
31 Mar 195,465205720
31 Mar 185,028268990
31 Mar 174,5902711190
31 Mar 164,0182161070
31 Mar 153,675186740

Quality Earnings: ARTEMISMED has high quality earnings.

Growing Profit Margin: ARTEMISMED's current net profit margins (5.6%) are higher than last year (5.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ARTEMISMED's earnings have grown significantly by 32.2% per year over the past 5 years.

Accelerating Growth: ARTEMISMED's earnings growth over the past year (27.3%) is below its 5-year average (32.2% per year).

Earnings vs Industry: ARTEMISMED earnings growth over the past year (27.3%) exceeded the Healthcare industry 25.3%.


Return on Equity

High ROE: ARTEMISMED's Return on Equity (10.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.